About this trial
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients hospitalized for any type of arrhythmia
Disqualifiers
Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.
Trial population
Patients hospitalized for various types of arrhythmia
Trial design
Cohort
Prospective
Treatments tested in this trial
Normal treatment with catheter ablation or medicine
DeviceRoutine clinical care with catheter ablation and/or medicine; real-world clinical cases
Drug Treatment
DrugRoutine clinical care with medicine; real-world clinical cases
Treatment groups
Trial outcomes
Primary outcomes
Arrhythmia recurrence
Recurrence of the arrhythmia after treatment
All-cause death
Death due to any reason
Secondary outcomes
Arrhythmia recurrence
Recurrence of the arrhythmia after treatment
All-cause death
Death due to any reason
Cardiovascular death
Death due to cardiovascular disease
Cardiovascular death
Death due to cardiovascular disease
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: